Filing Details
- Accession Number:
- 0001127602-14-021783
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-27 17:31:28
- Reporting Period:
- 2014-06-25
- Filing Date:
- 2014-06-27
- Accepted Time:
- 2014-06-27 17:31:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1126490 | F Richard Pops | Connaught House 1 Burlington Road Dublin 4 Ireland | Director And Ceo, Alkermes Plc | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2014-06-25 | 50,000 | $12.30 | 570,063 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2014-06-25 | 49,800 | $49.87 | 520,263 | No | 4 | S | Direct | |
| Ordinary Shares | Disposition | 2014-06-25 | 200 | $50.70 | 520,063 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2014-06-25 | 50,000 | $0.00 | 50,000 | $12.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,000 | 2014-07-12 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.595 to $50.59. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.65 to $50.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request
- These options are fully vested in accordance with their terms.
Billionaire Hedge Funds
